Nanoparticle-Mediated Delivery of Flavonoids: Impact on Proinflammatory Cytokine Production: A Systematic Review

• Published in: Biomolecules (Basel, Switzerland) Vol. 13; no. 7; p. 1158
• Main Authors: Stevens Barrón, Jazmín Cristina, Chapa González, Christian, Álvarez Parrilla, Emilio, De la Rosa, Laura Alejandra
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.07.2023; MDPI
• Subjects: Analysis; Antioxidants; Automation; Bioavailability; Cardiovascular disease; Care and treatment; Controlled release; cytokine; Cytokines; drug delivery; flavonoid; Flavonoids; Flavonoids - pharmacology; Health aspects; Inflammation; Inflammatory diseases; Interleukin 18; Interleukin 6; Isoflavones; Liposomes; Molecular mechanics; nanoparticle; Nanoparticles; Plants; release; Review; Systematic review; Tumor Necrosis Factor-alpha; Tumor necrosis factor-TNF; Tumor necrosis factor-α; Mexico; cytokine; encapsulation; bioavailability; inflammation; release; in vitro; nanoparticle; in vivo; drug delivery; flavonoid
• ISSN: 2218-273X; 2218-273X
• DOI: 10.3390/biom13071158

Flavonoids are a diverse group of plant-derived compounds that have been shown to have various health benefits, including anti-inflammatory effects. However, their use in the treatment of inflammatory diseases has been limited due to their low bioavailability. The nanoparticle-mediated delivery of flavonoids has been proposed as a potential solution to this issue, as it allows the sustained release of the flavonoids over time. There are several different nanoparticle systems that have been developed for flavonoid delivery, including polymeric nanoparticles, liposomes, and inorganic nanoparticles. This systematic review aims to evaluate the impact of nanoparticle-mediated delivery of flavonoids on pro-inflammatory cytokine production in various diseases. We analyzed the performance of flavonoid-encapsulated nanoparticles in regulating cytokine production in different in vitro and in vivo studies. To this end, we followed the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) to conduct a comprehensive search of the literature and to assess the quality of the included studies. The results showed that flavonoid-encapsulated nanoparticles significantly downregulated pro-inflammatory cytokines, such as TNF-α, IL-1β, IL-6, and IL-18. In some cases, this effect was significantly greater than that observed with non-encapsulated flavonoids These findings suggest that nanoparticle-mediated delivery of flavonoids may have potential as a therapeutic approach for the treatment of inflammatory diseases.